ESR1 and breast carcinoma: Ample evidence has pointed out that ER-positive/HER2-positive breast cancers are more likely to metastasize to bone, while studies regarding survival outcome between various HR statuses in HER2-positve or negative breast cancer with bone metastasis are limited till now.